Hypothyroidism in β-thalassemia intermedia patients with and without Hydroxyurea

Iranian Journal of Medical Sciences

Volumn 39, Issue 1, 2014, Pages 60-63

  Zekavat, Omid Reza ^a   Makarem, Ali Reza ^b   Haghpanah, Sezaneh ^a   Karamizadeh, Zohreh ^c   Javad, Parvin ^a   Karimi, Mehran ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hydroxyurea; Thalassemia intermedia; Thyroid function

Indexed keywords

FERRITIN; HYDROXYUREA; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BETA THALASSEMIA; CHILD; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; IRAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; YOUNG ADULT;

EID: 84891441039     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341:99-109. doi: 10.1056/ NEJM199907083410207. PubMed PMID: 10395635.
2. Taher A, Isma'eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006;37:12-20. doi: 10.1016/j. bcmd.2006.04.005. PubMed PMID: 16737833.
3. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, et al. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005;127:1523-30. doi: 10.1378/ chest.127.5.1523. PubMed PMID: 15888823.
4. Olivieri NF. Reactivation of fetal hemoglobin in patients with beta-thalassemia. Semin Hematol. 1996;33:24-42. PubMed PMID: 8714583.
5. Karimi M, Darzi H, Yavarian M. Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005;27:380-5. doi: 10.1097/01. mph.0000174386.13109.28. PubMed PMID: 16012328.
6. Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M. Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia. Blood. 2003;102:1529-30. PubMed PMID: 12702505.
7. Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115:1886-92. doi: 10.1182/blood- 2009-09-243154. PubMed PMID: 20032507.
8. Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood. 2010;115:2354-63. doi: 10.1182/blood-2009- 05-221333. PubMed PMID: 19903897.
9. Karimi M, Cohan N, Mousavizadeh K, Falahi MJ, Haghpanah S. Adverse effects of hydroxyurea in beta-thalassemia intermedia patients: 10 years' experience. Pediatr Hematol Oncol. 2010;27:205-11. doi: 10.3109/08880011003639952. PubMed PMID: 20367264.
10. Grundy RG, Woods KA, Savage MO, Evans JP. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child. 1994;71:128-32. doi: 10.1136/adc.71.2.128. PubMed PMID: 7944532; PubMed Central PMCID: PMC1029942.
11. De Sanctis V, De Sanctis E, Ricchieri P, Gubellini E, Gilli G, Gamberini MR. Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study. Pediatr Endocrinol Rev. 2008;6:174-80. PubMed PMID: 19337174.
12. Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid. 2002;12:151-4. PubMed PMID: 11916284.
13. Mariotti S, Pigliaru F, Cocco MC, Spiga A, Vaquer S, Lai ME. β-thalassemia and thyroid failure: is there a role for thyroid autoimmunity? Pediatr Endocrinol Rev. 2011;8:307-9. PubMed PMID: 21705983.
14. Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96:488-491. doi: 10.1160/TH06-05-0267. PubMed PMID: 17003927.